Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION

(MCK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

MCKESSON CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
03/17/2020 | 03:14pm EDT

Item 7.01 Regulation FD Disclosure

On March 17, 2020, the Company issued and posted on its website a press release regarding a previously-announced investor call on March 17, 2020 to discuss the Company's completion of the exit of its investment in Change Healthcare LLC. In that press release, the Company also provided an updated forecast of its Adjusted Earnings per diluted share for full-year fiscal 2020. A copy of that press release is attached as Exhibit 99.1.

The information contained in this item, including Exhibit 99.1, is furnished to the Commission, but shall not be deemed "filed" with the Commission for purposes of Section 18 of the Securities Exchange Act of 1934 ("Exchange Act"), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, except as expressly stated in any such filing.



Item 9.01   Financial Statements and Exhibits.
(d) Exhibits.


Exhibit No.                                  Description

       99.1       Press release issued by the Company dated March 17, 2020
        104     Cover Page Interactive Data File - the cover page iXBRL tags are
                embedded within the Inline XBRL document



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on MCKESSON CORPORATION
05/29MCKESSON CORPORATION : Ex-dividend day for
FA
05/28MCKESSON : Investigators from US Oncology Research and McKesson Present Data Hig..
PU
05/28INCYTE : Pemazyre Available Exclusively at Biologics by McKesson
AQ
05/27MCKESSON : Pemazyre (pemigatinib) Available Exclusively at Biologics by McKesson
PU
05/22MCKESSON : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
05/20MCKESSON : Assumes No Second Wave of Covid-19 Cases In Planning for Fiscal Year
DJ
05/20MCKESSON : Beats Expectations for 4Q, Warns of Covid-19 Challenges Ahead
DJ
05/20MCKESSON : Fiscal 4Q Earnings Snapshot
AQ
05/20MCKESSON CORP : Results of Operations and Financial Condition (form 8-K)
AQ
05/20MCKESSON : Reports Fiscal 2020 Fourth-Quarter and Full-Year Results
BU
More news